2017-05195. Office of The Director, National Institutes of Health; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee on Research on Women's Health.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications associated with the Specialized Centers of Research program and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Advisory Committee on Research on Women's Health.

    Date: April 4, 2017.

    Open: 9:00 a.m. to 2:30 p.m.

    Agenda: Opening Remarks, Director's Report, NIH Legislative Update, and Scientific Presentations.

    Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.

    Closed: 2:30 p.m. to 4:30 p.m.

    Agenda: To evaluate the Specialized Centers of Research (SCORs) program proposed for ORWH's Strategic Plan.

    Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.

    Contact Person: Elizabeth Spencer, R.N., Deputy Director, Office of Research on Women's Health, Executive Secretary, ACRWH, 6707 Democracy Blvd., Bethesda, MD 20817, 301-402-1770, elizabeth.spencer@nih.gov.

    Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

    Information is also available on the Institute's/Center's home page: www4.od.nih.gov/​orwh/​,, where an agenda and any additional information for the meeting will be posted when available.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

    Start Signature

    Dated: March 9, 2017.

    Anna Snouffer,

    Deputy Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2017-05195 Filed 3-15-17; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
03/16/2017
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2017-05195
Dates:
April 4, 2017.
Pages:
14021-14021 (1 pages)
PDF File:
2017-05195.pdf